Myriad Genetics (MYGN) Lower after JPMorgan Downgrades to Underweight

Article Stock Quotes (1) Comments (0)

Shares of Myriad Genetics (NASDAQ: MYGN) are down 4.8% to $26.34 after JPMorgan the stock from Neutral to Underweight with a price target of $26.00.

For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• William Blair Cuts 3D Systems (DDD) to Underperform; Too Much Hype, Future is Cloudy
• Atlantic Equities Downgrades Walt Disney (DIS) to Neutral
• BofA/Merrill Lynch Downgrades Manning & Napier (MN) to Underperform

Create E-mail Alert Related Categories

Downgrades, Hot Downgrades

Related Entities

JPMorgan

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?